Palopegteriparatide (TransCon PTH) ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
235	副甲状腺機能低下症	1

235. 副甲状腺機能低下症

臨床試験数 : 88 / 薬物数 : 107 - (DrugBank : 24) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 7

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05654701 (ClinicalTrials.gov)	March 2023	8/12/2022	Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism	Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism	Hypoparathyroidism	Drug: Palopegteriparatide (TransCon PTH)	Ascendis Pharma Bone Diseases A/S	NULL	Available	18 Years	N/A	All			NULL